Hartfalen: epidemiologie, risicofactoren en toekomst

RIVM Rapport 260401006
resynchronization therapy for mild-to-moderate heart failure. N Engl J Med
363, 2385-95.
Tang WH, Katz R, Brennan ML, Aviles RJ, Tracy RP, Psaty BM, Hazen SL (2009).
Usefulness of myeloperoxidase levels in healthy elderly subjects to predict
risk of developing heart failure. Am J Cardiol 103, 1269-74.
Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA,
Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H,
Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van Der Wall EE,
Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO,
Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML,
Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR,
Wallentin LC, Fernandez-Aviles F, Fox KM, Parkhomenko AN, Priori SG,
Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V,
Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD,
Mcgregor K, Sechtem U, Silber S, Widimsky P, Zamorano JL, Morais J, Brener
S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN,
Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar N (2007). Universal definition
of myocardial infarction. Circulation 116, 2634-53.
Tribouilloy C, Rusinaru D, Mahjoub H, Souliere V, Levy F, Peltier M, Slama M,
Massy Z (2008). Prognosis of heart failure with preserved ejection fraction: a
5 year prospective population-based study. Eur Heart J 29, 339-47.
Truong QA, Cannon CP, Zakai NA, Rogers IS, Giugliano RP, Wiviott SD, Mccabe
CH, Morrow DA, Braunwald E (2009). Thrombolysis in Myocardial Infarction
(TIMI) Risk Index predicts long-term mortality and heart failure in patients
with ST-elevation myocardial infarction in the TIMI 2 clinical trial. Am Heart J
157, 673-9 e1.
Tschöpe C, Kasner M, Westermann D, Gaub R, Poller WC, Schultheiss HP
(2005). The role of NT-proBNP in the diagnostics of isolated diastolic
dysfunction: correlation with echocardiographic and invasive measurements.
Eur Heart J 26, 2277-84.
Turnbull F. (2003). Effects of different blood-pressure-lowering regimens on
major cardiovascular events: results of prospectively-designed overviews of
randomised trials. Lancet 362(9395): 1527-1535.
Vaartjes I, Peters RJG, Dis SJ van, Bots ML (2007). Hart- en vaatziekten in
Nederland 2007, cijfers over leefstijl- en risicofactoren, ziekte en sterfte. Den
Haag: Nederlandse Hartstichting.
Vaartjes I, Bots ML (2008). Hartfalen, cijfers en feiten. Den Haag: Nederlandse
Hartstichting.
Vaartjes I, Hoes AW, Reitsma JB, De Bruin A, Grobbee DE, Mosterd A, Bots MI
(2010). Age- and gender-specific risk of death after first hospitalization for
heart failure. BMC Public Health 10, 637.
Vaes B, De Ruijter W, Gussekloo J, Degryse J (2009). The accuracy of plasma
natriuretic peptide levels for diagnosis of cardiac dysfunction and chronic
heart failure in community-dwelling elderly: a systematic review. Age Ageing
38, 655-62.
Van Baal PH, Hoogenveen RT, EngelfrietPM, Boshuizen HC (2010). Indirect
estimation of chronic disease excess mortality. Epidemiology 21(3): 425-6.
Van den Hurk K (2011). Diabetes and the Heart. Thesis, Vrije Universiteit,
Amsterdam.
Van der Meer FM, Couwenbergh BTLE, Enzing JJ, Ligtenberg G, Staal PC (2010).
De gecombineerde leefstijlinterventie: kosten, opbrengsten en de praktijk.
College voor zorgverzekeringen. Rapportnr. 2010047390, 2010.
Van Hee VC, Adar SD, Szpiro AA, Barr RG, Bluemke DA, Diez Roux AV, Gill EA,
Sheppard L, Kaufman JD (2009). Exposure to traffic and left ventricular mass
Pagina 113 van 122